Clindamycin phosphate
NDC 43066-993, Clindamycin phosphate, injection, solution, from Baxter Healthcare Corporation.
- Product NDC
- 43066-993
- Status
- Listed
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208084
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43066-993 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CLINDAMYCIN PHOSPHATE600 mg/50mL
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE]; Lincosamide Antibacterial [EPC]; Lincosamides [CS]; Neuromuscular Blockade [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43066-993-24 | 43066099324 | 24 BAG in 1 CASE (43066-993-24) / 50 mL in 1 BAG |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1a42c3b2-90b5-4a78-9f18-fa789742b033Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=43066-993
Use it
Look up 43066-993 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43066-993 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43066-993. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.